BackPhaseBio Pharmaceuticals Overview

PhaseBio Pharmaceuticals Total Revenue

Revenue analysis for PHAS.

Quarterly Revenue

$208000.00
↓ 97.99% YoY

As of Jun 2022

Annual Revenue (TTM)

$818000.00
↓ 92.27% YoY

Trailing 12 months ending Jun 2022

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin